Researchers conducted a cohort study to compare lung cancer risk among patients with COPD and T2DM using SGLT2 inhibitors vs sulfonylureas.
Background Pulmonary rehabilitation (PR) is the cornerstone of non-pharmacological treatment for chronic obstructive ...
Advancements in COPD treatment are offering relief to thousands of Kentuckians by targeting inflammation directly without the ...
Patients with asthma or COPD who used semaglutide for type 2 diabetes experienced significant reductions in their ...
Cigarette smoke exposure is associated with the development and severity of chronic obstructive pulmonary disease, or COPD, which is the third leading cause of death worldwide. Cigarette smoke ...
Tozorakimab cut moderate/severe COPD exacerbations up to 34% in the phase 3 trials OBERON and TITANIA across smoking status ...
Dual bronchodilation with umeclidinium/vilanterol improved exercise cardiac function in patients with COPD, hyperinflation, ...
Based on real-world records from the U.K., affected patients who went on any GLP-1 receptor agonist for a comorbid condition ...
A small trial found that laughter therapy and pursed-lip breathing reduced reported breathlessness in people with COPD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results